FIELD: chemistry.
SUBSTANCE: compounds exhibit antagonistic activity towards the EP4 receptor, which enables use thereof as an active ingredient in a pharmaceutical composition for treating chronic kidney disease or diabetic nephropathy.
EFFECT: high efficiency of the compounds.
27 cl, 228 tbl, 86 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | 2019 |
|
RU2795374C2 |
AMINOPYRAZOLE DERIVATIVE | 2010 |
|
RU2580543C9 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2014 |
|
RU2653500C2 |
AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
AMIDE DERIVATIVES OF PYROSOL | 2015 |
|
RU2658827C2 |
DERIVATIVE OF THIENOPYRAZOLE, HAVING ACTIVITY THAT INHIBITS PHOSPHODIESTERASE 7(PDE 7) | 2005 |
|
RU2376309C2 |
INDOLE-2-CARBOXAMIDES AS INHIBITORS OF FACTOR Xa AND/OR VIIa, MEDICINAL AGENT BASED ON THEREOF AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2299881C2 |
NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
PERI-SUBSTITUTED ARYLSULPHONAMIDE BICYCLIC COMPOUNDS FOR TREATING ARTERY OCCLUSIVE DISEASES | 2005 |
|
RU2407736C2 |
PIPERIDINE DERIVATIVE | 2008 |
|
RU2470020C2 |
Authors
Dates
2013-04-20—Published
2009-05-12—Filed